New York, July 07, 2014 -- The global healthcare industry has seen an uptick in M&A activity in 2014, as healthcare organizations seek higher earnings growth and diversification benefits, Moody's Investors Service says in its latest edition of Healthcare Quarterly. In this issue, Moody's looks at the credit implications of the deal frenzy gripping six sub-sectors of the healthcare industry. The value of global healthcare deals announced in the first half of 2014 including hostile bids exceeds $300 billion, driven in part by a very acquisitive pharmaceuticals sector.
Vollständigen Artikel bei Moodys lesen